Sacubitril/valsartan in PARADIGM-HF Reply

被引：0
|
作者：
Seferovic, Jelena P. [1 ]
Claggett, Brian [1 ]
Solomon, Scott D. [1 ]
机构：
[1] Harvard Med Sch, Brigham & Womens Hosp, Cardiovasc Div, 75 Francis St, Boston, MA 02115 USA
来源：
LANCET DIABETES & ENDOCRINOLOGY | 2017年 / 5卷 / 07期
关键词：
HEART-FAILURE; ENALAPRIL;
D O I：
10.1016/S2213-8587(17)30179-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：496 / 496
页数：1
相关论文
共 50 条
  • [11] Asymptomatic versus symptomatic hypotension in HFrEF: Findings with sacubitril/valsartan in PARADIGM-HF
    Matsumoto, Shingo
    Shen, L.
    Henderson, A. D.
    Desai, A. S.
    Kober, L.
    Lefkowitz, M. P.
    Packer, M.
    Rouleau, J. L.
    Solomon, S. D.
    Swedberg, K.
    Vaduganathan, M.
    Voors, A. A.
    Zile, M.
    Jhund, P. S.
    Mcmurray, J. J. V.
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 : 250 - 251
  • [12] Effect of sacubitril/valsartan on investigator-reported ventricular arrhythmias in PARADIGM-HF
    Curtain, James P.
    Jackson, Alice M.
    Shen, Li
    Jhund, Pardeep S.
    Docherty, Kieran F.
    Petrie, Mark C.
    Castagno, Davide
    Desai, Akshay S.
    Rohde, Luis E.
    Lefkowitz, Martin P.
    Rouleau, Jean-Lucien
    Zile, Michael R.
    Solomon, Scott D.
    Swedberg, Karl
    Packer, Milton
    McMurray, John J., V
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (03) : 551 - 561
  • [13] sacubitril/valsartan in PARADIGM-HF (Expression of Concern of Vol 5, Pg 495, 2017)
    LANCET DIABETES & ENDOCRINOLOGY, 2019, 7 (04): : 250 - +
  • [14] Comparison of angioedema in heart failure patients treated with sacubitril/valsartan or enalapril in PARADIGM-HF
    Packer, M.
    Streefkerk, H.
    Thorburn, C.
    Shi, V.
    Zhou, W.
    Schwende, H. Heike
    Kaplan, A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 : 459 - 460
  • [15] CONSISTENT BENEFIT OF SACUBITRIL/VALSARTAN OVER ENALAPRIL, IRRESPECTIVE OF BACKGROUND THERAPY IN PARADIGM-HF
    Okumura, Naoki
    Jhund, Pardeep
    Gong, Jianjian
    Lefkowitz, Martin
    Rizkala, Adel
    Rouleau, Jean
    Shi, Victor
    Solomon, Scott
    Swedberg, Karl
    Zile, Michael
    Packer, Milton
    McMurray, John J. V.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 1456 - 1456
  • [16] Clinical Profile of a Nonselected Population Treated With Sacubitril/Valsartan Is Different From PARADIGM-HF Trial
    Vicent, Lourdes
    Esteban-Fernandez, Alberto
    Gomez-Bueno, Manuel
    De-Juan, Javier
    Diez-Villanueva, Pablo
    Manuel Iniesta, Angel
    Ayesta, Ana
    Gonzalez-Saldivar, Hugo
    Rojas-Gonzalez, Antonio
    Bover-Freire, Ramon
    Iglesias, Diego
    Garcia-Aguado, Marcos
    Perea-Egido, Jesus A.
    Martinez-Selles, Manuel
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2018, 72 (02) : 112 - 116
  • [17] Prognostic importance of heart rate, and effect of sacubitril/valsartan according to heart rate, in PARADIGM-HF
    Castagno, D.
    Jhund, P.
    Rouleau, J. L.
    Swedberg, K.
    Zile, M. R.
    Lefkowitz, M. P.
    Shi, V. C.
    Solomon, S. D.
    Packer, M.
    Mcmurray, J. J. V.
    EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 : 120 - 121
  • [18] Effects of sacubitril/valsartan on glycemia in patients with diabetes and heart failure: the PARAGON-HF and PARADIGM-HF trials
    Wijkman, Magnus O.
    Claggett, Brian
    Vaduganathan, Muthiah
    Cunningham, Jonathan W.
    Rorth, Rasmus
    Jackson, Alice
    Packer, Milton
    Zile, Michael
    Rouleau, Jean
    Swedberg, Karl
    Lefkowitz, Martin
    Shah, Sanjiv J.
    Pfeffer, Marc A.
    McMurray, John J. V.
    Solomon, Scott D.
    CARDIOVASCULAR DIABETOLOGY, 2022, 21 (01)
  • [19] B-TYPE NATRIURETIC PEPTIDE DURING TREATMENT WITH SACUBITRIL/VALSARTAN: THE PARADIGM-HF TRIAL
    Vaduganathan, Muthiah
    Myhre, Peder
    Claggett, Brian
    Packer, Milton
    Desai, Akshay S.
    Rouleau, Jean L.
    Zile, Michael R.
    Swedberg, Karl
    Lefkowitz, Martin
    Shi, Victor
    McMurray, John J. V.
    Solomon, Scott D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 3073 - 3073
  • [20] Effects of sacubitril/valsartan on glycemia in patients with diabetes and heart failure: the PARAGON-HF and PARADIGM-HF trials
    Magnus O. Wijkman
    Brian Claggett
    Muthiah Vaduganathan
    Jonathan W. Cunningham
    Rasmus Rørth
    Alice Jackson
    Milton Packer
    Michael Zile
    Jean Rouleau
    Karl Swedberg
    Martin Lefkowitz
    Sanjiv J. Shah
    Marc A. Pfeffer
    John J. V. McMurray
    Scott D. Solomon
    Cardiovascular Diabetology, 21
12345